Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer
Authors:
- Marika CrohnsMCMarika Crohns
- Kari LiippoKLKari Liippo
- Marina ErholaMEMarina Erhola
- Hannu KankaanrantaHKHannu Kankaanranta
- Eeva MoilanenEMEeva Moilanen
- Hannu AlhoHAHannu Alho
- Pirkko Kellokumpu-LehtinenPKPirkko Kellokumpu-Lehtinen
- 1 August 2009
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (12) , 1236-1245
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Small cell lung cancer: Treatment reviewRespirology, 2006
- A Review of First-Line Treatment for Small-cell Lung CancerJournal of Thoracic Oncology, 2006
- Oxidant/antioxidant Parameters and their Relationship with Chemotherapy in Hodgkin's LymphomaJournal of International Medical Research, 2005
- Chemoradiotherapy for lung cancer: current status and perspectivesInternational Journal of Clinical Oncology, 2004
- Small cell lung cancer: state of the art and future perspectivesLung Cancer, 2004
- Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantationFree Radical Biology and Medicine, 2000
- Adriamycin Induces Protein Oxidation in Erythrocyte MembranesBasic & Clinical Pharmacology & Toxicology, 1998
- 5-Hydroxymethyluracil excretion, plasma tbars and plasma antioxidant vitamins in adriamycin-treated patientsFree Radical Biology and Medicine, 1996
- Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patientsFree Radical Biology and Medicine, 1996
- Lipid Peroxides in the Polychemotherapy of Cancer PatientsChemotherapy, 1994